CLINICAL_TRIALS
trial_result
· 2016-03-10
Clinical Trial Update: A Study to Assess Pharmacokinetics (PK) of Preladenant in Participants With Chronic Renal Impairment (CRI) (P06512) [Phase 1]
Summary
Phase 1 pharmacokinetics study of preladenant in participants with chronic renal impairment completed; results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED | Results posted: 2016-03-10